PU-H39
PU-H39 is a selective Grp94 inhibitor with an IC50 of 0.12 μM. PU-H39 can be used for the research of breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 852030-38-7
- 화학식: C16H13Cl2N5S
- 분자량:378.28
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SK-BR-3 | IC50 |
>500 μM
Compound: 11l
|
Inhibitory concentration against SKBr3 cell line
Inhibitory concentration against SKBr3 cell line
|
[PMID: 15828828] |
| SK-BR-3 | IC50 |
500 μM
Compound: 11l
|
Inhibitory concentration against SKBr3 cell line
Inhibitory concentration against SKBr3 cell line
|
[PMID: 15828828] |
In Vitro
PU-H39 (compound 9g) shows minimal off-target binding to kinases at 10 μM, exhibiting 34% and 32% inhibition of MKNK2 and ROCK2 kinases respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 852030-38-7
-
분자량 378.28
-
화학식 C16H13Cl2N5S
-
SMILES
ClC1=CC=C(SC2=NC=3C(=NC=NC3N2CCCC#C)N)C(Cl)=C1
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)